Predicted to enable potassium:proton antiporter activity and sodium:proton antiporter activity. Predicted to be involved in inorganic cation transmembrane transport and regulation of intracellular pH. Predicted to be active in plasma membrane. Is expressed in brain. Human ortholog(s) of this gene implicated in end stage renal disease. Orthologous to human SLC9A5 (solute carrier family 9 member A5). [provided by Alliance of Genome Resources, Apr 2022]